GSK in good health
By Research Desk
about 12 years ago
Glaxosmithkline Consumer Healthcare is currently the top gainer on the BSE. The stock is up 5% at Rs.4213.60, with an intra day high at Rs.4230.
The stock is doing well on two counts. Firstly, after the HUL buy back announcement, there is a general feeling in the market that many other MNCs will also make such offers and GSK is also undergoing the same set of expectations though with promoters stake at Rs.72.46%, that happening seems unlikely.
The surge is more on account of its enthusing numbers for first quarter ending 31st March 2013. The company’s total income was up 17% (YoY) at Rs.975 crore and net profit rose 18% at Rs.1561 crore. EPS for the quarter was up from Rs.31.38 to Rs.37.19 (face value Rs 10).